By Jasmine Li
Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the telehealth startup.
Amazon on Thursday launched the treatments through its One Medical telehealth service, and Amazon Prime members are eligible for free shipping, the company said.
Hims & Hers's stock is down 25% in Thursday trading. Shares have more than doubled this year, due in part to the company's introduction of weight-loss treatments in May. Amazon's online pharmacy partnered with Lilly in March to fill prescriptions for the weight-loss drug Zepbound.
Hims & Hers gained popularity as one of the first companies to directly ship hair and skin treatments to telehealth patients. The company said this month it had more than 2 million subscribers in the third quarter, a 40% boost from a year ago.
Amazon's push into low-cost treatments follows its launch of Haul, a budget online storefront similar to Temu or Shein.
Amazon said Prime members can access these treatments starting at:
-- Anti-aging skin-care: $10 a month
-- Men's hair loss: $16 a month
-- Erectile dysfunction treatment: $19 a month
-- Eyelash growth: $43 a month
-- Motion sickness treatment: $2 a month
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
November 14, 2024 15:15 ET (20:15 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。